NASDAQ:MSONMisonix Stock Price, Forecast & News

$13.18

-0.13 (-0.98 %)

(As of 06/3/2020 04:00 PM ET)

Add

Compare

Today's Range

$13.18

Now: $13.18▼

$14.20

50-Day Range

$10.09

MA: $11.90▼

$13.93

52-Week Range

$6.71

Now: $13.18▼

$27.54

Volume104,600 shs

Average Volume94,480 shs

Market Capitalization$228.83 million

P/E RatioN/A

Dividend YieldN/A

Beta1.31

Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Misonix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $17.67, Misonix has a potential upside of 34.0% from its current price of $13.18.
Amount of Analyst Coverage
Misonix has only been the subject of 2 research reports in the past 90 days.

2.3 Community Rank

Outperform Votes
Misonix has received 118 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Misonix has received 140 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Misonix has received 54.26% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote “Outperform” if you believe MSON will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Misonix does not currently pay a dividend.
Dividend Growth
Misonix does not have a long track record of dividend growth.

4.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Misonix insiders have bought more of their company's stock than they have sold. Specifically, they have bought $98,400.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 32.81% of the stock of Misonix is held by insiders.
Percentage Held by Institutions
37.63% of the stock of Misonix is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Misonix is -17.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Misonix is -17.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Misonix has a P/B Ratio of 5.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.96 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Laboratory apparatus & furniture

Sub-IndustryN/A

SectorComputer and Technology

Current SymbolNASDAQ:MSON

Previous Symbol

CUSIPN/A

CIK880432

Webwww.misonix.com

Phone631-694-9555

Debt

Debt-to-Equity Ratio0.26

Current Ratio4.91

Quick Ratio4.00

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$38.85 million

Price / Sales5.89

Cash FlowN/A

Price / Cash FlowN/A

Book Value$2.25 per share

Price / Book5.86

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-7,390,000.00

Net Margins-19.18%

Return on Equity-9.13%

Return on Assets-6.69%

Miscellaneous

Employees118

Outstanding Shares17,362,000

Market Cap$228.83 million

Next Earnings Date8/12/2020 (Estimated)

OptionableNot Optionable

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.

Misonix (NASDAQ:MSON) Frequently Asked Questions

How has Misonix's stock been impacted by COVID-19 (Coronavirus)?

Misonix's stock was trading at $10.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MSON shares have increased by 23.4% and is now trading at $13.18. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Misonix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Misonix.

When is Misonix's next earnings date?

Misonix is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Misonix.

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) posted its quarterly earnings results on Monday, May, 11th. The medical equipment provider reported ($0.34) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.30) by $0.04. The medical equipment provider had revenue of $17.90 million for the quarter. Misonix had a negative return on equity of 9.13% and a negative net margin of 19.18%. View Misonix's earnings history.

What price target have analysts set for MSON?

2 equities research analysts have issued twelve-month price objectives for Misonix's stock. Their forecasts range from $13.00 to $22.00. On average, they anticipate Misonix's stock price to reach $17.67 in the next twelve months. This suggests a possible upside of 34.0% from the stock's current price. View analysts' price targets for Misonix.

Has Misonix been receiving favorable news coverage?

News coverage about MSON stock has been trending extremely negative recently, according to InfoTrie. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Misonix earned a news sentiment score of -4.0 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the immediate future. View the latest news aboutMisonix.

Who are some of Misonix's key competitors?

Some companies that are related to Misonix include Simulations Plus (SLP), QAD (QADA), Virtusa (VRTU), Anterix (ATEX), 3D Systems (DDD), Ceres Power (CWR), Celestica (CLS), Upland Software (UPLD), Ultra Clean (UCTT), Axcelis Technologies (ACLS), Tucows (TC), Onespan (OSPN), Nlight (LASR), Monotype Imaging (TYPE) and Calix (CALX). View all competitors.

What other stocks do shareholders of Misonix own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Second Sight Medical Products (EYES), Sociedad Quimica y Minera de Chile (SQM), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY) and AbbVie (ABBV).

Who are Misonix's key executives?

Misonix's management team includes the following people:

Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

Who are Misonix's major shareholders?

Misonix's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (3.74%), Juniper Investment Company LLC (2.28%), Soleus Capital Management L.P. (1.37%), Geode Capital Management LLC (0.97%), State Street Corp (0.84%) and Millrace Asset Group Inc. (0.37%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Sharon W Klugewicz and Stavros G Vizirgianakis. View institutional ownership trends for Misonix.

Which major investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, UBS Group AG, and Rathbone Brothers plc. View insider buying and selling activity for Misonix.

Which major investors are buying Misonix stock?

MSON stock was acquired by a variety of institutional investors in the last quarter, including Juniper Investment Company LLC, Millrace Asset Group Inc., Soleus Capital Management L.P., BlackRock Inc., Geode Capital Management LLC, Two Sigma Investments LP, Mesirow Financial Investment Management Inc., and State Street Corp. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Sharon W Klugewicz, and Stavros G Vizirgianakis. View insider buying and selling activity for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $13.18.

How big of a company is Misonix?

Misonix has a market capitalization of $228.83 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe.

What is Misonix's official website?

The official website for Misonix is www.misonix.com.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.

This page was last updated on 6/3/2020 by MarketBeat.com Staff